InventHelp Inventor Develops New Product for Breastfeeding Mothers (CWC-195)
PITTSBURGH, Nov. 7, 2023 /PRNewswire/ -- "We wanted to create an additional means of securing the collection bottle to the flange when using a breast pump," said one of two inventors, from Mt. Vernon, Ind., "so we invented the MOMMY BOTTLE SOCKET. Our design prevents the bottle from falling and losing precious breast milk."
The patent-pending invention provides an effective means of covering and securing the collection bottle when pumping breast milk. In doing so, it helps prevent spillage of breast milk. It also helps to reduce the anxiety associated with constantly monitoring the milk level. As a result, it could provide a more positive breastfeeding experience. The invention features a practical design that is easy to use so it is ideal for nursing mothers.
The original design was submitted to the Kansas City sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 21-CWC-195, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.
Bruker Corporation today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company's common stock. The dividend will be paid on June 17, 2024 to stockholders of record as...
OmniAb, Inc. today announced its participation in the 20th Annual PEGS Boston ? The Essential Protein & Antibody Engineering Summit underway at the Omni Hotel. Earlier today the Company presented an overview of xPloration, a high-throughput single...
QuidelOrtho Corporation has launched a second state-of-the-art United States distribution center in Pedricktown, New Jersey. This strategic endeavor epitomizes QuidelOrtho's commitment to strengthening supply chain resilience and elevating the...
Nutcracker Therapeutics, Inc., a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, today detailed data presented by its partners at the University of California, San Francisco...
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today...
Omeros Corporation , a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic disorders including...
